返回 Agenda
SESSION 4: CONCERNS OF THE AUDIENCE AND STUDY REVIEW
Session Chair(s)
Michael Forstner, PHD, MPH, MSC
Managing Director, Head of Pharmacoepidemiology Practice
Mesa Laubela-Consulting, Switzerland
Gro Laier, MD
PV Expert
Denmark
Participants will be asked to submit questions at least two weeks in advance of the course, which will be addressed in plenum.
In addition, two published studies representing different approaches to PASS trials will be made ready for presentation and discussion. Participants will receive a presentation of the issue, develop and discuss a proposed solution in plenum, thereafter the trainers will present what was actually done.
Speaker(s)
CONCERNS OF THE AUDIENCE AND STUDY REVIEW
Michael Forstner, PHD, MPH, MSC
Mesa Laubela-Consulting, Switzerland
Managing Director, Head of Pharmacoepidemiology Practice
CONCERNS OF THE AUDIENCE AND STUDY REVIEW
Michael Forstner, PHD, MPH, MSC
Mesa Laubela-Consulting, Switzerland
Managing Director, Head of Pharmacoepidemiology Practice
CONCERNS OF THE AUDIENCE AND STUDY REVIEW
Michael Forstner, PHD, MPH, MSC
Mesa Laubela-Consulting, Switzerland
Managing Director, Head of Pharmacoepidemiology Practice